37. 膿疱性乾癬(汎発型) Generalised pustular psoriasis Clinical trials / Disease details
臨床試験数 : 74 / 薬物数 : 53 - (DrugBank : 20) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 101
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03885089 (ClinicalTrials.gov) | October 21, 2019 | 4/3/2019 | Infliximab Biosimilar for Intravenous Drip Infusion 100 mg Pfizer Drug Use Investigation (Psoriasis) | Infliximab BS for Intravenous Drip Infusion 100 mg Pfizer General Investigation (Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, or Erythrodermic Psoriasis) | Psoriasis Vulgaris;Psoriasis Arthropathica;Pustular Psoriasis;Erythrodermic Psoriasis | Drug: Infliximab [infliximab biosimilar 3] | Pfizer | NULL | Recruiting | N/A | N/A | All | 100 | Japan | |
2 | JPRN-jRCTs031180367 | 20/02/2018 | 18/03/2019 | The effect of infliximab on endothelial function in patients with psoriasis | A pilot study for the effect of infliximab on endothelial function in patients with psoriasis | Psoriasis vulgaris, Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis Psoriasis vulgaris, Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis;D011565, D015535 | Endothelial function is measured in patients with psoriasis treated with infliximab before and after the first, second, and third infusions. | TOYAMA SATOSHI | NULL | Not Recruiting | >= 20age old | < 80age old | Both | 25 | N/A | Japan |
3 | JPRN-UMIN000027208 | 2017/06/01 | 01/06/2017 | A pilot study for the effect of infliximab on endothelial function in patients with psoriasis | A pilot study for the effect of infliximab on endothelial function in patients with psoriasis - The effect of infliximab on endothelial function in patients with psoriasis | Psoriasis vulgaris, Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis | Endothelial function is measured in patients with psoriasis treated with infliximab before and after the first, second, and third infusions. | The University of Tokyo Hospital | NULL | Recruiting | 20years-old | 80years-old | Male and Female | 25 | Not applicable | Japan |